Poland· PL-100084896
Selgres
A selegiline product containing selegilinum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Selegiline is registered in 14 of 19 countries.
Countries holding a registration under ATC N04BD01 (selegiline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Selegiline · ATC N04BD01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of selegiline costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.24 in Italy to $0.62 in France — a ×2.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Selegiline · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- FR France$0.62
- IT Italy$0.24
The record
At a glance
URPL (Poland)- Active substance
- Selegilinum
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- N04BD01
- ATC class
- Selegiline
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- gtin0590999040431550 szt.PLN 19.26
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
187 interactions on record for selegiline.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Selegiline · interactions on record
187 records
- 35 severe
- 115 moderate
- 1 minor
- 21 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OpiumA07DA02severe
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
15 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Selegiline in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEldepryl 10mg tabletsOrion Pharma (UK) Ltd
- United StatesEMSAMViatris Specialty LLC
- FinlandEldeprylOrion Corporation Orion Pharma
- NorwayEldeprylOrion Corporation
- GermanySelegilin Al 10Aliud Pharma Gmbh
- ItalyJUMEXCHIESI ITALIA S.P.A.
- SwedenEldepryl 10 mg TablettOrion Corporation
- BelgiumEldepryl 10 mgOrion
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Eldepryl
- Bulgaria · Jamax, Селегос
- Cyprus · Selegos, Selex
- Germany · Selegilin Neuraxpharm
- Denmark · Eldepryl
- Spain · Plurimen
- Finland · Eldepryl
- France · Deprenyl
- United Kingdom (Northern Ireland) · Eldepryl, Selegiline Hydrochloride Activase Pharmaceuticals
- Greece · Feliselin
- Ireland · Eldepryl
- Italy · Jumex, Selecom
- Luxembourg · Eldepryl
- Latvia · Eldepryl
- Norway · Eldepryl
- Portugal · Selegilina Generis
- Romania · Selegos
- Sweden · Eldepryl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5596e45-c82e-4df7-a366-ef31df7065f2 GET /v1/drugs/b5596e45-c82e-4df7-a366-ef31df7065f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909990404315 ¦ Rp ¦ 44181\n50 tabl.",
"substance": "Selegilini hydrochloridum 5 mg",
"common_name": "Selegilinum",
"pl_product_id": "100084896",
"pozwolenie_nr": "04043",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about selegiline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.